1. Introduction
===============

Oral candidiasis is one of the most common opportunistic infections with varying clinical manifestations that affect the oral cavity. Based on previous studies, Candida albicans is the most common etiologic agent for this condition ([@b1-epj-08-2752], [@b2-epj-08-2752]). Research has shown a significant correlation between Candida colonies in children and early carious lesions during childhood ([@b3-epj-08-2752], [@b4-epj-08-2752]). Polyenes (*nystatin*) and azoles (fluconazole) are the most commonly-used local agents for the treatment of candidiasis; however, due to the presence of resistant species of Candida, toxicity, and insufficient bioavailability, only a small number of these agents are effective therapeutically ([@b5-epj-08-2752]). In recent decades, plant derivatives have attracted a lot of attention ([@b6-epj-08-2752]). One of these plants with excellent therapeutic properties is *Lippia citriodora* from the Verbena family. The plant is indigenous to North America; however, it has been planted in some European countries and in Iran in regions with moderate weather conditions (northern areas) under greenhouse conditions due to its beneficial properties ([@b7-epj-08-2752]). The leaves of this plant have aromatic constituents, which are used to prepare traditional tea. *L. citriodora* has been listed as one of the safe plants and use of its alcoholic and traditional tea forms has been considered safe ([@b8-epj-08-2752]). *Citral* (*geranial, neral*), *geraniol*, lemonene, and cineol are the main ingredients of the extract of L. citriodora ([@b9-epj-08-2752]). This plant is used in traditional medicine for the treatment of asthma, spasms, colds, colic, diarrhea, malabsorption, and anxiety ([@b10-epj-08-2752]). Evaluation of the biological activity and ingredients isolated from the extract and leaf extract of *L. citriodora* showed its anti-oxidative, anti-microbial, anti-inflammatory, and anti-fungal activities and analgesic effects as a result of its *phenolic acid*, *flavonoid*, and *terpenoid* compounds. The essential oils of *L. citriodora* decrease cellular lysis due to oxidative stresses, and they are a good candidate for conditions leading to neuronal degradation ([@b8-epj-08-2752], [@b10-epj-08-2752]--[@b13-epj-08-2752]). The aim of the present study was to determine the inhibitory effect of the aqueous and *ethanolic* extracts of *L. citriodora* leaves on *Candida albicans* isolated from the dorsum of the tongue of patients and the standard strain in culture media.

2. Material and Methods
=======================

2.1. Study design and setting
-----------------------------

In this in vitro study, we used the standard strain of *Candida albicans* (PTCC 5027) procured from the Industrial Microorganism Collection Center of Iran and 15 *C. albicans* samples isolated from the dorsum of the tongue of 4--12-year-old children who were referred to the Department of Pediatric Dentistry of Babol University of Medical Sciences. The inclusion criteria consisted of no use of anti-microbial mouthwashes during the past month and no use of anti-fungal agents, antihistamines and corticosteroids, and a caries index \> 4. The samples were collected after briefing the children's parents and obtaining informed written consent forms. The samples were immediately cultured on Sabouraud dextrose agar plates (Scharlau-Merck, Germany) in association with chloramphenicol. After fungal growth, a part of the colony was transferred to the CHROMagar culture medium (CHROMagar Candida, Paris, France). C. albicans species was confirmed by the color produced on the CHROMagar medium and formation of a germ tube in serum and production of vesicles in the cornmeal agar median (Himedia Laboratories, Ltd, Mumbai, India) plus 1% Tween 80. Then, a suspension of 48-hour yeast colonies was prepared in the Sabouraud Dextrose Agar with Chloramphenicol medium with the use of physiologic serum. Then, a standard 0.5 McFarland concentration was prepared using the well technique with the disk placemat method. Microdilutions of yeasts were prepared at 5×10^2^ -- 2.5×10^3^ in each mL with the use of RPMI medium (Sigma-Aldrich, Germany).

2.2. Preparation of aqueous and ethanolic leaf extract of L. citriodora
-----------------------------------------------------------------------

*L. citrodora* leaves were collected from the Research Garden of Babol University of Medical Sciences in May 2015, rinsed, dried at room temperature for 27 hours, and milled. To prepare the aqueous extract, 30 g of the dry powder of the leaves were mixed with 100 mL of water at 70--80 °C, which had already been boiled, and stored at room temperature for 24 hours. The resultant extract was filtered through Whatman filter papers (Whatman No. 1) and placed in an oven at 40--50 °C for drying. The dry weight of the material was determined. This extract was considered the aqueous extract of *L. citriodora*. To prepare the *ethanolic* extract, 75 g of the dry material and 250 mL of 95% dehydrated ethanol were poured in a beaker, and, after 48 hours, the resultant solution was filtered through No. 1 Whatman paper filters and dried in a vacuum machine. The dry *ethanolic* extract was weighed. This extract was considered the dry *ethanolic* extract.

2.3. Evaluation of the antifungal activity with the use of disk diffusion technique
-----------------------------------------------------------------------------------

Sterile paper disks were immersed in the final concentrations of 156--2500 μg/mL of the aqueous (dissolved in water) and *ethanolic* (dissolved in dimethyl *sulfoxide*, DMSO) extracts, 4--64 μg/mL of fluconazole (dissolved in water) and 8--128 μg/mL of *nystatin* (dissolved in *dimethyl sulfoxide*, DMSO) and then dried. The suspension prepared from *C. albicans* in sterile physiologic serum was spread on a plate containing Sc medium using a sterile swab. Five disks containing different concentrations of the aqueous and *ethanolic* extracts of *L. citriodora*, *nystatin* and fluconazole were placed separately in each plate. The disks were placed at a distance of 15 mm from the plate margin and 24 mm from the center of the adjacent disk. A disk with no preparation and a disk with 0.2% DMSO were considered as negative controls. Then, the diameter of the transparent halo around each disk was measured. Halo diameters ≥2 mm indicated antifungal activity ([@b14-epj-08-2752]). All of the plates were prepared in duplicate and incubated at 37 °C for 48 hours.

2.4. Evaluation of the antifungal activity using the well technique
-------------------------------------------------------------------

The suspension prepared from *C. albicans* in sterile physiologic serum was inoculated on a plate containing *Sabouraud dextrose agar* culture medium along with chloramphenicol with the use of a sterile swab. After two hours, cavities measuring 6 mm in diameter were prepared in it. Different concentrations of the aqueous extract (dissolved in water), *ethanolic* extract (dissolved in DMSO), fluconazole (dissolved in water) and *nystatin* (dissolved in DMSO) were added to the wells. All of the plates were prepared in duplicate and incubated at 37 °C for 48 hours.

2.5. Microdilution to determine the minimum inhibitory concentration (MIC)
--------------------------------------------------------------------------

MIC was determined with the use of CLSI-M27-A3 (Clinical and Laboratory Standard Institute) standard technique to determine the inhibitory and lethal effect of the medication ([@b15-epj-08-2752]). Nine series of different concentrations of the extract were prepared in duplicate at the final concentrations of 19--5000 μg/mL, 0.25--64 μg/mL of fluconazole, 0.5--128 μg/mL *nystatin* in a total volume of 100 μL in sterile 96-well ELISA plates with flat bottoms, containing 100 μL of RPMI. Then, the fungal suspension at concentrations of 5×10^2^ -- 2.5×10^3^ yeast cells/mL was added to the plates at a volume of 100 μL. All of the plates were prepared in duplicate and incubated at 35 °C for 48 hours. Positive and negative controls and DMSO solution also were considered.

2.6. Statistical analysis
-------------------------

The data were analyzed using Tukey's post hoc and One-Way ANOVA tests using SPSS 18 software, and they were expressed as the mean ± the standard error of the mean (SEM). The data obtained from the *ethanolic* and aqueous extracts of lemon verbena were compared with the findings of the control group fluconazole and *nystatin* and p \< 0.05 was considered statistically significant.

3. Results
==========

In the present in vitro study, the samples were collected from 22 volunteers as follows: 10 subjects in the 4--6 age group and 12 in the 7--12 age group, with mean DMFT score of 5.5 and 8.6 respectively. Of the 22 samples cultured, two were not *C. albicans* samples, and no fungal growth was detected in five samples. The presence of green colonies in 15 CHROMagar culture media indicated the growth of *C. albicans* ([Figure 1](#f1-epj-08-2752){ref-type="fig"}). In addition, all of these microorganisms produced germ tubes and vesicles (*chlamydoconidium*) in the cornmeal agar along with 1% Tween 80 in 13 plates ([Figure 2](#f2-epj-08-2752){ref-type="fig"}). In this study, the anti-fungal activities of different concentrations of aqueous and *ethanolic* extracts of *L. citiodora* leaves against *C. albicans* were evaluated with the use of disk diffusion, well, and microdilution techniques in comparison to *nystatin* and fluconazole.

In the well and disk diffusion techniques, small growth inhibitory halos were observed around a number of clinically-isolated stains; however, no inhibitory halos were observed around the standard strains. In addition, the aqueous extract exhibited no inhibitory halos in the disk diffusion and well techniques. The diameters of growth inhibitory halos with *nystatin*-containing disks (with the minimum concentration of 8 μg/mL around the isolated and standard stains) were 0.53 ± 0.53 and 0; the maximum diameters of growth inhibitory halos at a concentration of 128 μg/mL around clinically-isolated and standard stains increased to 16.13 ± 0.44 and 17 in a dose-dependent manner. In addition, the growth inhibitory halos in the same order in the well technique with the minimum *nystatin* concentration were 0.535 ± 0.55 and 0, and, with the maximum concentration, they were 17.8 ± 0.59 and 17. The growth inhibitory halo diameters for 4 μg/mL of fluconazole with the clinically isolated and standard strains in the disk diffusion technique were 0.57 ± 0.55 and 0, and in the well technique they were 0 and 0. With the maximum concentration (64 μg/mL), the diameters were 15.53 ± 1.28 and 17, and 17.33 ± 0.36 and 18, respectively. MICs are presented in [Table 1](#t1-epj-08-2752){ref-type="table"}. The MIC results showed a higher inhibitory effect of *ethanolic* extract of *L. citriodora* than its aqueous extract. In addition, the standard strain exhibited higher sensitivity than the clinically isolated C. albicans strains at the concentrations evaluated. Although no growth inhibitory halos were detected in the disks and wells containing the aqueous extract, in the MIC technique, the growth inhibitions for the clinical and standard strains were 833 ± 78.5 and 2500 μg/mL, respectively. The MIC of the *ethanolic* extract was 833 ± 78.5 and 625 μg/mL for the isolated and standard strains, respectively, indicating higher inhibitory potential for the *ethanolic* extract than the aqueous extract (p = 0). In addition, the MIC of *nystatin* for clinical and standard strains was 10.13 ± 1.91 and 4, respectively, with 1.97 ± 0.25 and 1 μg/mL, respectively for fluconazole. Although the MIC of the *ethanolic* extract of *L. citriodora* was higher than those of *nystatin* and fluconazole (p = 0), this extract exhibited anti-fungal activity.

4. Discussion
=============

The present study evaluated the anti-fungal effects of aqueous and *ethanolic* extracts of *L. citriodora* leaves on *C. albicans*. The results showed that 15 colonies of these fungal species were green in color in the CHROMagar culture medium, indicating the presence of *C. albicans*. In addition, all of these colonies produced germ tubes, and 13 strains produced vesicles (*Chlamydoconidium*) in the cornmeal agar medium. A previous study showed the anti-oxidative activity of leaf extract of L. citriodora. In addition, the anti-microbial and anti-fungal properties of *L. citriodora* leaves have been attributed to aromatic and *polyphenolic* compounds in the leaves ([@b16-epj-08-2752]--[@b18-epj-08-2752]). In the present study, the effects of aqueous and *ethanolic* extracts of *L. citriodora* leaves were evaluated using the disk diffusion, well diffusion, and MIC techniques. In the well and disk diffusion techniques, limited growth inhibition halos were produced around some clinical isolates at different concentrations of the *ethanolic* extract; however, no growth inhibitory halos were observed with any concentrations of the aqueous extract. Absence of growth inhibitory halos around disks containing the extract might be attributed to the fact that, in the present study, a lower concentration of the extract was used compared to previous studies. In addition, since the effective material in the well and disk diffusion technique gradually diffuses into the environment and affects the margins of the growing colonies, the fungal species in question had the opportunity to make use of its defensive mechanisms to counteract the material's toxicity through a proper technique; however, in the micro-dilution technique, mixing of the extract with the culture medium resulted in the presence of the effective material in all the areas of the environment. Therefore, it can be expected that the threshold of response of each fungal species to the anti-fungal agent will be different ([@b19-epj-08-2752]). The MICs of *ethanolic* extract, in the present study, on clinically isolated and standard strains were 833 ± 78.5 and 625 μg/mL, respectively, which were much lower than those in a 2005 study by Oskay, which showed that the MIC of *methanolic* extract of *L. citriodora* leaves on *C. albicans* was 6 mg/mL ([@b20-epj-08-2752]). In the present study, inhibition occurred at a lower concentration than that in the study by Oskay, which might be attributed to higher levels of polyphenols and aromatic compounds in the extract ([@b13-epj-08-2752], [@b17-epj-08-2752]). In the present study, the MICs of the aqueous extracts with clinically isolated and standard strains were 4156 ± 67.4 and 2500 μg/mL respectively, indicating a lower inhibitory potential of the aqueous extract than the *ethanolic* extract. In a 2013 study by Koohsari, the antibacterial effects of aqueous and *ethanolic* extracts of *L. citriodora* were evaluated at concentrations of 125--1000 mg/mL on nine pathogenic species with the use of disk diffusion and well techniques. The results showed that the *ethanolic* extract exhibited an antibacterial effect; however, the aqueous extract had no inhibitory effect on the pathogenic species. The results showed that *E. faecalis*, *S. epidermidis*, and *S. aureus* were the most sensitive bacteria among gram-positive bacteria and that *Y. enterocolitica* was the most resistant gram-negative bacterial species ([@b14-epj-08-2752]). Most plant extracts have anti-microbial properties and consist of saturated organic or aromatic compounds. In most cases, *ethanolic* or *methanolic* solvents are used for their initial extraction and, typically in the majority of studies, the use of water is avoided for extraction of plant derivatives ([@b21-epj-08-2752]). Since the presence of phenolic components in plant extracts is one of the main reasons for their anti-microbial effects, it is possible that the presence of very small amounts of phenolic compounds in the aqueous extract was the reason for the low anti-microbial effect of this extract ([@b17-epj-08-2752]). Lozada, in a 2012 study, evaluated the effect of the essential oils of *L. citriodora* and *L. origanoid* on growth inhibition of *Moniliophthora roreri*, and the results showed complete inhibition of fungal growth at concentrations of 600--1000 μg/mL ([@b22-epj-08-2752]). Observations in relation to the essential oils of *L. citriodora* showed its high anti-bacterial activity against *H. pylori* ([@b23-epj-08-2752]). A 2010 study by Ramzi showed that *L. citriodora* extract has an inhibitory effect on gram-positive bacteria, but it had no effect on Candida maltosa ([@b24-epj-08-2752]). In 2012, Ansari conducted a study with 1/2, 1/4, 1/8, and 1/16 concentrations of 100μl of *L. citriodora* extract using disk diffusion technique to determine MIC against *S. aureus* strain resistant to methicillin. The results showed that the inhibitory effect increased with an increase in the concentration of the extract up to 55 μg/mL. In addition, the MIC was determined at 15 μg/mL, and the results showed a high anti-microbial activity against methicillin-resistant *S. aureus* despite very low toxicity against cells ([@b25-epj-08-2752]). The anti-bacterial activity of the extract might be attributed to the presence of alkaloids, flavonoids, and tannin in its chemical structure ([@b23-epj-08-2752]). Tatsadjieu evaluated the antifungal activity of *Lippia rugosa* leaves and showed that *geraniol*, *neral*, and *geranial* in the extract were the agents responsible for the anti-fungal activity against *Aspergillus flavus* ([@b26-epj-08-2752]). A study in 2009 by Royaro showed that the extract of *L. citriodora* leaves exhibited the highest anti-fungal activity at inhibitory concentrations of 99.21 and 65.5 μg/mL against C. krusei and Aspergillus fumigatus, respectively ([@b22-epj-08-2752]). A study in 2012 by Lozada showed that the essential oils of *L. citriodora* and *L. origanoid* resulted in 90% inhibition of fungal growth at a concentration of 200 μg/mL; however, 100% inhibition was achieved at concentrations in the range of 800--1000 μg/mL ([@b27-epj-08-2752]). A study in 2007 by Oliviera on the antibacterial activity of *L. origanoid* with the use of drop diffusion technique showed its inhibitory effects on gram-positive microorganisms, including *S. aureus* and *C. albicans* ([@b28-epj-08-2752]). A study in 1994 by Villon and Chaumont showed the antifungal activity of *Lippia multiflora* and *Lippia chevalieri* extracts against *Aspergillus flavus*. They reported that *trepenoids*, especially *citral* and *geraniol* that are present in extract of L. *citriodora*, were responsible for the anti-fungal activity ([@b29-epj-08-2752]). Other anti-fungal agents are *beta-caryophyllene* and *beta-caryophyllene* oxide that belong to *cisquiterpens* and are found in the plant extracts of *Lippia rehmanii* and *Lippia citriodora* ([@b30-epj-08-2752]). Despite the complications reported in previous studies in relation to other antifungal agents, no side effects have been reported after the use of leaf extract of *L. citriodora*; on the contrary, its positive protective effects on the general health have been shown ([@b7-epj-08-2752], [@b10-epj-08-2752], [@b11-epj-08-2752], [@b16-epj-08-2752], [@b30-epj-08-2752], [@b31-epj-08-2752]).

5. Conclusions
==============

The results of the present study showed that the aqueous extract, and particularly the *ethanolic* extract, of the leaves of *L. citriodora* has activity against *C. albicans*, which might be attributed to the higher content of aromatic agents, including essences and polyphenols, in the *ethanolic* extract compared to the aqueous extract. Use of this extract can be suggested to volunteers, after evaluating them, as an agent against *C. albicans*.
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###### 

Means and standard deviation of minimal inhibitory concentration (MIC) of *Aqueous* and *Ethanolic* extracts of *Lippia citriodora, Nystatin* and *Fluconazol*e against *Candida albicans*

  Extracts        Range (μg/ml)   MIC (μg/ml)    
  --------------- --------------- -------------- ------
  *Aqueous*       19--5000        4156 ± 67.4    2500
  *Ethanolic*     19--5000        833 ± 78.5     625
  *Nystatin*      0.5--128        10.13 ± 1.91   4
  *Fluconazole*   0.25 -- 64      1.97 ± 0.25    1
